Engineered tumor-targeted cytokine/antibody fusion proteins for cancer immunotherapy

被引：0
|
作者：
Jamie, Spangler B. [1 ]
机构：
[1] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA
来源：
CANCER SCIENCE | 2025年 / 116卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
AACR1-3
引用
收藏
页码：129 / 129
页数：1
相关论文
共 50 条
  • [31] Influence of antigen density and immunosuppressive factors on tumor-targeted costimulation with antibody-fusion proteins and bispecific antibody-mediated T cell response
    Sabrina Sapski
    Nadine Beha
    Roland E. Kontermann
    Dafne Müller
    Cancer Immunology, Immunotherapy, 2020, 69 : 2291 - 2303
  • [32] Influence of antigen density and immunosuppressive factors on tumor-targeted costimulation with antibody-fusion proteins and bispecific antibody-mediated T cell response
    Sapski, Sabrina
    Beha, Nadine
    Kontermann, Roland E.
    Mueller, Dafne
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2020, 69 (11) : 2291 - 2303
  • [33] Antibody-cytokine fusion proteins
    Kontermann, Roland E.
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2012, 526 (02) : 194 - 205
  • [34] Novel tumor-targeted, engineered IL-2 variant (IL-2v)-based immunocytokines for immunotherapy of cancer.
    Klein, Christian
    Inja, Waldhauer
    Nicolini, Valeria
    Claire, Dunn
    Freimoser, Anne
    Freimoser, Anne
    Herter, Sylvia
    Geven, Edwin
    Boerman, Otto
    van Puijenbroek, Erwin
    Wittig, David
    Moser, Samuel
    Ast, Oliver
    Hosse, Ralf
    Lang, Sabine
    Neumann, Sebastian
    Grossmann, Adelbert
    Gorr, Ingo
    Evers, Stefan
    Pisa, Pavel
    Fretland, Jennifer
    Levitsky, Victor
    Gerdes, Christian
    Bacac, Marina
    Moessner, Ekkehard
    Moessner, Ekkehard
    Umana, Pablo
    CANCER RESEARCH, 2013, 73
  • [35] Molecularly engineered siRNA conjugates for tumor-targeted RNAi therapy
    Lee, Jong Won
    Choi, Jiwon
    Choi, Yeonho
    Kim, Kwangmeyung
    Yang, Yoosoo
    Kim, Sun Hwa
    Yoon, Hong Yeol
    Kwon, Ick Chan
    Journal of Controlled Release, 2022, 351 : 713 - 726
  • [36] Molecularly engineered siRNA conjugates for tumor-targeted RNAi therapy
    Lee, Jong Won
    Choi, Jiwon
    Choi, Yeonho
    Kim, Kwangmeyung
    Yang, Yoosoo
    Kim, Sun Hwa
    Yoon, Hong Yeol
    Kwon, Ick Chan
    JOURNAL OF CONTROLLED RELEASE, 2022, 351 : 713 - 726
  • [37] Design and characterization of a tumor-retained interleukin-2 cytokine/antibody fusion protein for cancer immunotherapy
    Silver, Aliyah Brianne
    Spangler, Jamie B.
    JOURNAL OF IMMUNOLOGY, 2023, 210 (01):
  • [38] Generation of tumor-targeted antibody-CpG conjugates
    Li, Zhongjun
    Jang, Julie K.
    Lechner, Melissa G.
    Hu, Peisheng
    Khawli, Leslie
    Scannell, Christopher A.
    Epstein, Alan L.
    JOURNAL OF IMMUNOLOGICAL METHODS, 2013, 389 (1-2) : 45 - 51
  • [39] Targeted Reconstitution of Cytokine Activity upon Antigen Binding using Split Cytokine Antibody Fusion Proteins
    Venetz, Dario
    Koovely, Danil
    Weder, Bruce
    Neri, Dario
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2016, 291 (35) : 18139 - 18147
  • [40] RGD-IL-24, A Novel Tumor-Targeted Fusion Cytokine: Expression, Purification and Functional Evaluation
    Bin Xiao
    Wei Li
    Jun Yang
    Gang Guo
    Xu-Hu Mao
    Quan-Ming Zou
    Molecular Biotechnology, 2009, 41 : 138 - 144
12345